Armored RNA Technology for Production of Ribonuclease-Resistant Viral RNA Controls and Standards

AUTOR(ES)

Pasloske, Brittan L.

FONTE

American Society for Microbiology

RESUMO

The widespread use of sensitive assays for the detection of viral and cellular RNA sequences has created a need for stable, well-characterized controls and standards. We describe the development of a versatile, novel system for creating RNase-resistant RNA. “Armored RNA” is a complex of MS2 bacteriophage coat protein and RNA produced in Escherichia coli by the induction of an expression plasmid that encodes the coat protein and an RNA standard sequence. The RNA sequences are completely protected from RNase digestion within the bacteriophage-like complexes. As a prototype, a 172-base consensus sequence from a portion of the human immunodeficiency virus type 1 (HIV-1) gag gene was synthesized and cloned into the packaging vector used to produce the bacteriophage-like particles. After production and purification, the resulting HIV-1 Armored RNA particles were shown to be resistant to degradation in human plasma and produced reproducible results in the Amplicor HIV-1 Monitor assay for 180 days when stored at −20°C or for 60 days at 4°C. Additionally, Armored RNA preparations are homogeneous and noninfectious.

Documentos Relacionados

• Characterization of ribonuclease-resistant RNA from poliovirus-infected HeLa cells.
• THE BIOSYNTHESIS OF TOBACCO MOSAIC VIRUS RNA: RELATIONSHIPS TO THE BIOSYNTHESIS OF VIRUS-SPECIFIC RIBONUCLEASE-RESISTANT RNA*
• Sequences of large T1 ribonuclease-resistant oligoribonucleotides from protamine mRNA: the overall architecture of protamine mRNA.
• A ribonuclease-resistant region of 5S RNA and its relation to the RNA binding sites of proteins L18 and L25.
• An RNasin-resistant ribonuclease selective for interleukin 2 mRNA.